Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Precancerous Conditions 1

Interventions

Polymerase Chain Reaction 4Selenium 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vitamin E 2Tacrolimus 2Radiotherapy, Intensity-Modulated 2Peripheral Blood Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mycophenolic Acid 2Mesna 2Melphalan 2Light Coagulation 2Cytogenetic Analysis 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Busulfan 2alpha-Tocopherol 1Watchful Waiting 1Vaginal Smears 1Soybean Proteins 1Rosuvastatin Calcium 1Paclitaxel 1Moxifloxacin 1Morphine 1Microarray Analysis 1In Situ Hybridization, Fluorescence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Soybean Proteins × Other neoplasm × Clear all
NCT00064194 2020-04-03

Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia

Canadian Cancer Trials Group

Phase 3 Completed
310 enrolled
GenitourinaryOther neoplasm

Precancerous Conditions, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡